Boycott, Kym M
$1,374,619.00 CAD
None of our seven automatic checks marked this record. What are the warning signs?
- Department
- Canadian Institutes of Health Research
- Program The named fund or plan that the money comes from.
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year The government's budget year. It starts on April 1 and ends on March 31. For example, 2023-2024 is from April 2023 to March 2024.
- 2024-2025
- Agreement period The start date and the end date of the deal. The money can be paid at different times in this period.
- April 1, 2024 – March 31, 2027
- Reference
- cihr-irsc:236-2024-2025-Q1-00260
Published purpose
The specific objectives of this funding opportunity are to: • Generate high quality evidence required to optimize the RD diagnosis pathway in Canada; • Evaluate the health outcomes associated with RDs via the ‘genomics first’ diagnosis pathway compared to the current approach (i.e., genomic testing performed later); • Determine the economic impact to the health care system for the ‘genomics first’ diagnosis pathway and compare to current diagnostic pathways for RDs; • Evaluate the socioeconomic and psychological impacts of delays in the diagnosis on patients/families with RDs from a diversity of population groups and communities in Canada using the ‘genomics first’ diagnostic paradigm as a comparator; and, • Mobilize knowledge to facilitate the implementation, scale and spread of best practices for diagnosing RDs in Canada.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.